Tom Brady is newest face of GLP-1s, joining telehealth startup
BostonGlobe.comJAN 17
Tom Brady Joins eMed as Wellness Chief Amid GLP-1 Boom
Are athletes democratizing access to life-changing weight loss treatments, or exploiting a cynical profit cycle?
Above: Tom Brady attends the launch of the new Fanatics Studios in Inglewood, Calif., on Jan. 13. Image credit: Monica Schipper/Getty Images
The Spin
Pro-establishment narrative
Access to effective weight loss treatments shouldn't be a luxury reserved for the wealthy. Companies like eMed are democratizing GLP-1 drugs by helping employers cover costs and offering affordable subscriptions, giving millions a real shot at long-term health. Athlete involvement brings credibility to comprehensive wellness programs that combine medication with expert care and sustainable lifestyle changes.
Establishment-critical narrative
The American economy thrives on a perverse cycle: corporations profit by making people sick, then sell them drugs as the solution. Brady is a prime example of this, pivoting from hawking unhealthy Pizza Hut to peddling weight loss medications — exposing a cynical business model in real time. Weight management is an intimate issue for many, and those dealing with it deserve honest help, not corporate gimmicks.
Metaculus Prediction
The Controversies
Articles on this story
© 2026 Improve the News Foundation. All rights reserved.Version 6.18.0
© 2026 Improve the News Foundation.
All rights reserved.
Version 6.18.0